Mechanisms of transcriptional repression by 1,25(OH)2 vitamin D

被引:21
|
作者
Kato, Shigeaki
Kim, Mi-sun
Yamaoka, Kazuyoshi
Fujiki, Ryoji
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
[2] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama, Japan
来源
关键词
coregulator; corepressor; transcriptional repression; vitamin D; vitamin D receptor;
D O I
10.1097/MNH.0b013e3281c55f16
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Vitamin D has diverse biological actions, and consequently the mechanisms behind how it regulates gene transcription are diverse. Unlike its well described positive effects on gene transcription; little is known about how vitamin D induces transcriptional repression. Recent findings Vitamin D-induced transcriptional repression of several negative vitamin D receptor target genes has been studied on a molecular level. A new class of negative vitamin D response elements, which are E-box-type motifs, bind the bHLH-type transcriptional activator (VDIR) together with a histone acetyltransferase coactivator. The vitamin D receptor, activated by vitamin D, does not directly bind to the negative vitamin D response elements, but instead associates with VDIR. This leads to the dissociation of the histone acetyltransferase coactivator and recruitment of a histone deacetylase corepressor to transrepress transcription of the target gene promoter. Summary Histone inactivation induced by histone deacetylase co-repressors appears to facilitate vitamin D-induced transcriptional repression via the vitamin D receptor. Following vitamin D binding, structural alteration of the DNA-unbound vitamin D receptor triggers transcriptional repression. Given this, the mechanisms behind vitamin D-induced transcriptional repression are probably more complex than those of vitamin D-induced transactivation.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 50 条
  • [21] Effects of vitamin D3, 25(OH)D, and 1,25(OH)2D on calcium absorption efficiency
    Barger-Lux, MJ
    Heaney, RP
    NUTRITIONAL ASPECTS OF OSTEOPOROSIS, 1998, : 229 - 236
  • [22] INTERACTION OF 1,25(OH)2VITAMIN-D (1,25D) WITH THE CAMP CLASS OF BIOLOGICAL SIGNALS
    CATHERWOOD, BD
    RUBIN, JE
    CLINICAL RESEARCH, 1985, 33 (01): : A100 - A100
  • [23] The proliferation and differentiation of human bone cells in response to 25(OH)D and 1,25(OH)2D: Local conversion of 25(OH)D into 1,25(OH)2D?
    van der Meijden, K.
    Bravenboer, N.
    Lips, P.
    BONE, 2011, 48 : S147 - S147
  • [24] SERUM25(OH)-VITAMIN D AND 1,25(OH)2 VITAMIN D IN HEMODIALYSIS PATIENTS: FACTORS AFFECTING THEIR CONCENTRATIONS AND THEIR EFFECT ON SURVIVAL
    Ishimura, Eiji
    Nakatani, Shinya
    Fujimoto, Takao
    Higashimoto, Kazunari
    Kosoku, Akihiro
    Okuno, Senji
    Kakiya, Ryusuke
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I858 - I859
  • [25] Circulating interferon-γ correlates with 1,25(OH)D and the 1,25(OH)D-to-25(OH)D ratio
    Barker, Tyler
    Martins, Thomas B.
    Kjeldsberg, Carl R.
    Trawick, Roy H.
    Hill, Harry R.
    CYTOKINE, 2012, 60 (01) : 23 - 26
  • [26] Association among plasma 1,25(OH)2D, ratio of 1,25(OH)2D to 25(OH)D, and prostate cancer aggressiveness
    Ramakrishnan, Swathi
    Steck, Susan E.
    Arab, Lenore
    Zhang, Hongmei
    Bensen, Jeannette T.
    Fontham, Elizabeth T. H.
    Johnson, Candace S.
    Mohler, James L.
    Smith, Gary J.
    Su, L. Joseph
    Woloszynska, Anna
    PROSTATE, 2019, 79 (10): : 1117 - 1124
  • [27] 1,25(OH)2 VITAMIN-D3 ASSAY IN THE HYPERCALCIURIA OF SARCOIDOSIS
    MEYRIER, A
    PAILLARD, F
    BOUILLON, R
    VALEYRE, D
    KIDNEY INTERNATIONAL, 1985, 28 (04) : 693 - 693
  • [28] PLASMA 1,25(OH)2 VITAMIN-D CONCENTRATIONS IN NUTRITIONAL OSTEOMALACIA
    PEACOCK, M
    HEYBURN, PJ
    AARON, J
    LANCET, 1979, 2 (8135): : 195 - 195
  • [29] EFFECT OF 1,25(OH)2-VITAMIN-D ON MAGNESIUM-METABOLISM
    LEVINE, BS
    WALLING, MW
    COBURN, JW
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 867 - 867
  • [30] 1,25(OH)2 VITAMIN-D PREVENTS INSULITIS IN NOD MICE
    MATHIEU, C
    LAUREYS, J
    WAER, M
    BOUILLON, R
    DIABETOLOGIA, 1992, 35 : A217 - A217